<?xml version="1.0" encoding="UTF-8"?>
<p>Cancer of the breast is the most important cause of mortalities in women all over the globe. Various chemotherapeutic treatments can be applied for its treatment. However, they are costly and accompanied by frightening side effects. In addition, cells in breast cancer are becoming resistant to the various available chemotherapies [
 <xref rid="B1" ref-type="bibr">1</xref>]. Therefore, it is mandatory to search for alternative treatment options that are efficient, cost-effective, and biocompatible. Recently, metal and metal oxide nanoparticles have developed as a stimulating area of research because of their widespread applications [
 <xref rid="B2" ref-type="bibr">2</xref>–
 <xref rid="B8" ref-type="bibr">8</xref>]. Nanobiotechnology has noteworthy applications in biomedical sciences as a field aiding therapeutics and diagnostics [
 <xref rid="B9" ref-type="bibr">9</xref>–
 <xref rid="B11" ref-type="bibr">11</xref>]. Recently, AgNPs have been comprehensively researched because of their interesting physical, biochemical, and therapeutic properties [
 <xref rid="B12" ref-type="bibr">12</xref>, 
 <xref rid="B13" ref-type="bibr">13</xref>].
</p>
